Literature DB >> 19129785

The ketogenic diet, four score and seven years later.

Douglas R Nordli1.   

Abstract

This Practice Point commentary discusses the findings of Neal et al.'s randomized controlled trial of the ketogenic diet in children with refractory epilepsies. The authors showed that the ketogenic diet was superior to continuation of medical treatment in reducing seizure frequency in this patient population. On the basis of these and other results I argue three points, the first being supported by the literature and the others being personal opinion. First, the ketogenic diet should be considered for the treatment of children with drug-resistant epilepsy and not only as a last resort. Second, the allocation of resources to support professionals in administering the ketogenic diet is justifiable. Third, we must develop alternative strategies to randomized controlled trials if we wish to obtain timely information on effective treatment strategies for specific pediatric epilepsy syndromes.

Entities:  

Year:  2009        PMID: 19129785     DOI: 10.1038/ncpneuro0985

Source DB:  PubMed          Journal:  Nat Clin Pract Neurol        ISSN: 1745-834X


  8 in total

1.  Medication cost reduction in children on the ketogenic diet: data from a prospective study.

Authors:  D L Gilbert; P L Pyzik; E P Vining; J M Freeman
Journal:  J Child Neurol       Date:  1999-07       Impact factor: 1.987

2.  Experience with the ketogenic diet in infants.

Authors:  D R Nordli; M M Kuroda; J Carroll; D Y Koenigsberger; L J Hirsch; H J Bruner; W T Seidel; D C De Vivo
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

Review 3.  Update on the epidemiology and prognosis of pediatric epilepsy.

Authors:  Shlomo Shinnar; John M Pellock
Journal:  J Child Neurol       Date:  2002-01       Impact factor: 1.987

4.  Ketogenic diet in patients with Dravet syndrome.

Authors:  Roberto Horacio Caraballo; Ricardo Oscar Cersósimo; Diego Sakr; Araceli Cresta; Nidia Escobal; Natalio Fejerman
Journal:  Epilepsia       Date:  2005-09       Impact factor: 5.864

5.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

6.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.

Authors:  Elizabeth G Neal; Hannah Chaffe; Ruby H Schwartz; Margaret S Lawson; Nicole Edwards; Geogianna Fitzsimmons; Andrea Whitney; J Helen Cross
Journal:  Lancet Neurol       Date:  2008-05-02       Impact factor: 44.182

7.  Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood.

Authors:  H Oguni; T Tanaka; K Hayashi; M Funatsuka; M Sakauchi; S Shirakawa; M Osawa
Journal:  Neuropediatrics       Date:  2002-06       Impact factor: 1.947

8.  The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children.

Authors:  J M Freeman; E P Vining; D J Pillas; P L Pyzik; J C Casey; L M Kelly
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

  8 in total
  1 in total

1.  M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate.

Authors:  Rían W Manville; Maria Papanikolaou; Geoffrey W Abbott
Journal:  J Pharmacol Exp Ther       Date:  2019-11-22       Impact factor: 4.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.